Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural dexmedetomidine + ropivacaine to prevent erection after reconstructive urethral surgery
IRCT20190131042569N4Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and ropivacaine in erectile dysfunction (ED), sponsored by Shahid Beheshti University of Medical Sciences. Started Aug 2020; status: completed.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on IRCT20190131042569N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190131042569N4.